Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrasekhar Bal

Showing results (21-30 of 328) with videos related to

Pageof 33
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|September 27, 2012
Renal and hematological toxicity in patients of neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-DOTATATESantosh K Gupta, Suhas Singla, Chandrasekhar Bal
Clinical Nuclear Medicine|February 26, 2016
PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?Sameer Kamalakar Taywade, Nishikant Avinash Damle, Chandrasekhar Bal
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 6, 2013
Solid variant of papillary carcinoma thyroid in a child with no history of radiation exposureNishikant Damle, Soundararajan Ramya, Chandrasekhar Bal, et al.
Nuclear Medicine Communications|July 5, 2012
A randomized equivalence trial to determine the optimum dose of iodine-131 for remnant ablation in differentiated thyroid cancerChandrasekhar Bal, Prem Chandra, Ajay Kumar, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 20, 2013
Vascular thrombosis as a cause of abdominal pain in a patient with neuroendocrine carcinoma of pancreas: Findings on (68)Ga-DOTANOC PET/CTNiraj Naswa, Rakesh Kumar, Chandrasekhar Bal, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|March 5, 2014
PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from IndiaPunit Sharma, Harmandeep Singh, Chandrasekhar Bal, et al.
BMJ Case Reports|November 10, 2020
Hyperplastic thyroid nodule masquerading as parathyroid adenoma in a patient with tubercular lymphadenitis induced hypercalcaemiaAlpesh Goyal, Shipra Agarwal, Ravinder Goswami, et al.
Nuclear Medicine Communications|November 11, 2010
Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancerAmburanjan Santra, Susan Bal, Sagar Mahargan, et al.
Thyroid : Official Journal of the American Thyroid Association|August 19, 2022
Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 YearsChandrasekhar Bal, Swayamjeet Satapathy, Avinash Tupalli, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|September 12, 2014
Non-ossifying fibroma mimicking distant metastasis of osteosarcoma on (99m)Tc-methylene diphosphonate bone scintigraphy: Diagnosis with single photon emission tomography/computed tomographyPunit Sharma, Harmandeep Singh, Chandrasekhar Bal, et al.
Pageof 33

Showing results (21-30 of 328) with videos related to

Sort By:
Pageof 33
Cancer Biotherapy & Radiopharmaceuticals|September 27, 2012
Renal and hematological toxicity in patients of neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-DOTATATESantosh K Gupta, Suhas Singla, Chandrasekhar Bal
Clinical Nuclear Medicine|February 26, 2016
PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?Sameer Kamalakar Taywade, Nishikant Avinash Damle, Chandrasekhar Bal
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 6, 2013
Solid variant of papillary carcinoma thyroid in a child with no history of radiation exposureNishikant Damle, Soundararajan Ramya, Chandrasekhar Bal, et al.
Nuclear Medicine Communications|July 5, 2012
A randomized equivalence trial to determine the optimum dose of iodine-131 for remnant ablation in differentiated thyroid cancerChandrasekhar Bal, Prem Chandra, Ajay Kumar, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 20, 2013
Vascular thrombosis as a cause of abdominal pain in a patient with neuroendocrine carcinoma of pancreas: Findings on (68)Ga-DOTANOC PET/CTNiraj Naswa, Rakesh Kumar, Chandrasekhar Bal, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|March 5, 2014
PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from IndiaPunit Sharma, Harmandeep Singh, Chandrasekhar Bal, et al.
BMJ Case Reports|November 10, 2020
Hyperplastic thyroid nodule masquerading as parathyroid adenoma in a patient with tubercular lymphadenitis induced hypercalcaemiaAlpesh Goyal, Shipra Agarwal, Ravinder Goswami, et al.
Nuclear Medicine Communications|November 11, 2010
Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancerAmburanjan Santra, Susan Bal, Sagar Mahargan, et al.
Thyroid : Official Journal of the American Thyroid Association|August 19, 2022
Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 YearsChandrasekhar Bal, Swayamjeet Satapathy, Avinash Tupalli, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|September 12, 2014
Non-ossifying fibroma mimicking distant metastasis of osteosarcoma on (99m)Tc-methylene diphosphonate bone scintigraphy: Diagnosis with single photon emission tomography/computed tomographyPunit Sharma, Harmandeep Singh, Chandrasekhar Bal, et al.
Pageof 33